254267788	254267788	CD	B-NP	O
|	|	NN	I-NP	O
AMC	AMC	NN	I-NP	O
|	|	NN	I-NP	O
70537348	70537348	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9842339	9842339	CD	B-NP	O
|	|	CC	I-NP	O
9/11/2006	9/11/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
decompensation	decompensation	NN	I-NP	O
,	,	,	O	O
hypoxia	hypoxia	NN	B-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/11/2006	9/11/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/6/2006	10/6/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
NORD	NORD	NNP	B-NP	O
,	,	,	O	O
JR	JR	NNP	B-NP	O
,	,	,	O	O
RAYMON	RAYMON	NNP	B-NP	O
G.	G.	NNP	I-NP	O
179-06-78-1	179-06-78-1	CD	I-NP	O
Lem	Lem	NNP	I-NP	O
,	,	,	O	O
North	North	NNP	B-NP	O
Dakota	Dakota	NNP	I-NP	O
30666	30666	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
5/12/06	5/12/06	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HALDI	HALDI	NNP	B-NP	O
,	,	,	O	O
WILEY	WILEY	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/12/06	5/12/06	CD	B-NP	O
by	by	IN	B-PP	O
MARTH	MARTH	NNP	B-NP	O
,	,	,	O	O
MARCOS	MARCOS	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
6	6	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
639445669	639445669	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
needs	need	VBZ	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/13/06	2/13/06	CD	B-NP	O
by	by	IN	B-PP	O
BAREFOOT	BAREFOOT	NNP	B-NP	O
,	,	,	O	O
DOMINIC	DOMINIC	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
needs	need	VBZ	B-VP	O
BISOPROLOL	BISOPROLOL	NNP	B-NP	O
FUMARATE	FUMARATE	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FINASTERIDE	FINASTERIDE	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
FOLIC	FOLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
continue	continue	VB	B-VP	O
your	your	PRP$	B-NP	O
original	original	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
lasix	lasix	NN	I-NP	O
scale	scale	NN	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
Insulin	Insulin	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Continue	Continue	VB	B-VP	O
your	your	PRP$	B-NP	B-protein
original	original	JJ	I-NP	I-protein
outpatient	outpatient	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
High	High	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
Call	Call	NNP	I-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
60	60	CD	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
DO	DO	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
supplemental	supplemental	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
7	7	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
12	12	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
Call	Call	VBP	B-VP	O
HO	HO	NN	B-NP	B-protein
if	if	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
350	350	CD	B-NP	O
If	If	IN	B-SBAR	O
ordered	order	VBN	B-NP	O
QAC	QAC	NN	I-NP	O
administer	administer	NN	I-NP	O
at	at	IN	B-PP	O
same	same	JJ	B-NP	O
time	time	NN	I-NP	O
as	as	IN	B-PP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
,	,	,	O	O
standing	stand	VBG	B-VP	O
insulin	insulin	NN	B-NP	O
aspart	aspart	NN	I-NP	O
order	order	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
ordered	order	VBN	B-NP	O
HS	HS	NN	I-NP	O
administer	administer	NN	I-NP	O
alone	alone	RB	B-ADVP	O
LANTUS	LANTUS	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
68	68	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
IMDUR	IMDUR	NNP	I-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/12	2/12	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
K-DUR	K-DUR	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
KCL	KCL	NNP	I-NP	I-protein
SLOW	SLOW	NNP	I-NP	I-protein
RELEASE	RELEASE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MEQ	MEQ	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
2/12	2/12	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
continue	continue	VB	B-VP	O
your	your	PRP$	B-NP	O
original	original	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
potassium	potassium	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
CCUMCO	CCUMCO	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/13/06	2/13/06	CD	B-NP	O
by	by	IN	B-PP	O
SALVAGGIO	SALVAGGIO	NNP	B-NP	O
,	,	,	O	O
NOAH	NOAH	NNP	B-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
MAGNESIUM	MAGNESIUM	NN	I-NP	O
OXIDE	OXIDE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
241	241	CD	I-NP	O
MG	MG	NNP	I-NP	O
ELEMENTAL	ELEMENTAL	NNP	I-NP	O
MG	MG	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
400	400	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Other	Other	NNP	I-NP	O
:	:	:	O	O
leg	leg	NN	B-NP	O
cramps	cramp	VBZ	B-VP	O
NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
0.4	0.4	CD	I-NP	I-protein
MG/SPRAY	MG/SPRAY	NNP	I-NP	I-protein
1-2	1-2	CD	I-NP	I-protein
SPRAY	SPRAY	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Chest	Chest	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
PREDNISONE	PREDNISONE	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	I-protein
MULTIVITAMIN	MULTIVITAMIN	NNP	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	I-protein
MULTIVI	MULTIVI	NNP	I-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
VITAMIN	VITAMIN	NNP	I-NP	O
E	E	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TOCOPHEROL-DL-ALPHA	TOCOPHEROL-DL-ALPHA	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
400	400	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6	6	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
6	6	CD	B-NP	O
mg	mg	NN	I-NP	O
tonight	tonight	RB	B-ADVP	O
,	,	,	O	O
then	then	RB	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/12/06	5/12/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
needs	need	VBZ	B-VP	O
Previous	Previous	NNP	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/13/06	2/13/06	CD	B-NP	O
by	by	IN	B-PP	O
HEADLAM	HEADLAM	NN	B-NP	O
,	,	,	O	O
LANE	LANE	NNP	B-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
674802608	674802608	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
needs	need	VBZ	B-VP	O
DIET	DIET	NN	B-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
Immediately	Immediately	RB	B-ADVP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Hymas	Hymas	NNP	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
,	,	,	O	O
Iodine	Iodine	NN	B-NP	O
contrast	contrast	NN	I-NP	O
dye	dye	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
decompensation	decompensation	NN	I-NP	O
,	,	,	O	O
hypoxia	hypoxia	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
decompensation	decompensation	NN	I-NP	O
,	,	,	O	O
hypoxia	hypoxia	NN	B-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
mi	mi	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cabg	cabg	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pvd	pvd	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
femoral	femoral	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
femoral	femoral	JJ	I-NP	O
popliteal	popliteal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholesterol	hypercholesterol	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
afib	afib	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chf	chf	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
dyspnea	dyspnea	NN	B-NP	O
,	,	,	O	O
hypoxia	hypoxia	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
73	73	CD	B-NP	O
yo	yo	NN	I-NP	O
Mwith	Mwith	IN	B-PP	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	I-NP	O
PCI	PCI	NN	I-NP	B-protein
,	,	,	O	O
iCMP	iCMP	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
EF	EF	NN	I-NP	I-protein
25-30	25-30	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
PVD	PVD	NN	B-NP	B-protein
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
PAF	PAF	NN	B-NP	B-protein
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
worsening	worsening	NN	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
progressively	progressively	RB	I-VP	O
worsening	worsen	VBG	I-VP	O
dyspnea	dyspnea	NN	B-NP	O
and	and	CC	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
several	several	JJ	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Dry	Dry	NN	B-NP	O
weight	weight	NN	I-NP	O
175	175	CD	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
181	181	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
stable	stable	JJ	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
and	and	CC	I-NP	O
sleeps	sleep	NNS	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
head	head	NN	I-NP	O
raised	raise	VBD	B-VP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

Increasing	Increase	VBG	B-VP	O
abdominal	abdominal	JJ	B-NP	O
girth	girth	NN	I-NP	O
.	.	.	O	O

Stable	Stable	JJ	B-NP	O
nocturia	nocturia	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
1-2	1-2	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
night	night	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Dry	Dry	NN	B-NP	O
persistent	persistent	JJ	I-NP	O
cough	cough	NN	I-NP	O
for	for	IN	B-PP	O
past	past	JJ	B-NP	O
several	several	JJ	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
complains	complain	VBZ	B-VP	O
of	of	IN	B-PP	O
dry	dry	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
and	and	CC	O	O
takes	take	VBZ	B-VP	O
a	a	DT	B-NP	O
lot	lot	NN	I-NP	O
of	of	IN	B-PP	O
ice	ice	NN	B-NP	B-protein
chips	chip	NNS	I-NP	I-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
does	do	VBZ	B-VP	O
restrict	restrict	VB	I-VP	O
his	his	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
intake	intake	VB	B-VP	O
to	to	TO	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
quarts	quart	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
am	am	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
acutely	acutely	RB	B-ADJP	O
short	short	JJ	I-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
upon	upon	IN	B-PP	O
waking	wake	VBG	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	B-PP	O
by	by	IN	B-PP	O
cyanotic	cyanotic	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
hands	hand	NNS	I-NP	O
and	and	CC	O	O
face	face	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
supplemental	supplemental	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
80s	80	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
use	use	VB	I-VP	O
oxygen	oxygen	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
baseline	baseline	NN	B-NP	O
angina	angina	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
nonradiating	nonradiating	JJ	I-NP	O
substerna	substerna	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
relived	relive	VBN	B-VP	O
by	by	IN	B-PP	O
nitro	nitro	NN	B-NP	B-protein
spray	spray	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

*************	*************	SYM	B-NP	O
PMHx	PMHx	NN	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
1981	1981	CD	I-NP	O
-LRB-	-LRB-	HYPH	O	O
3v	3v	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
1993	1993	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
5v	5v	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

S/P	S/P	NN	B-NP	B-protein
PCI	PCI	NN	I-NP	I-protein
with	with	IN	B-PP	O
DES	DES	NN	B-NP	O
to	to	TO	B-PP	O
LM	LM	NN	B-NP	O
and	and	CC	I-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
PLV	PLV	NN	B-NP	B-protein
Ischemic	Ischemic	JJ	I-NP	I-protein
CMP	CMP	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
EF	EF	NN	I-NP	I-protein
30	30	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
PAF	PAF	NN	I-NP	I-protein
ICD	ICD	NN	I-NP	I-protein
placed	place	VBD	B-VP	I-protein
10/25	10/25	CD	B-NP	I-protein
Hyperlipidemia	Hyperlipidemia	NNP	I-NP	I-protein
Mild	Mild	NNP	I-NP	I-protein
AI	AI	NNP	I-NP	I-protein
IDDM	IDDM	NNP	I-NP	I-protein
PMR	PMR	NN	I-NP	I-protein
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
S/p	S/p	NN	I-NP	O
Bilateral	Bilateral	JJ	I-NP	O
CEA	CEA	NN	I-NP	O
1995	1995	CD	I-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	O
with	with	IN	B-PP	O
claudication	claudication	NN	B-NP	O
,	,	,	O	O
S/p	S/p	NNP	B-NP	O
Bilateral	Bilateral	NNP	I-NP	O
Fem-Pop	Fem-Pop	NNP	I-NP	O
bypass	bypass	IN	B-PP	O
1995	1995	CD	B-NP	O
,	,	,	O	O
Central	Central	JJ	B-NP	B-protein
retinal	retinal	JJ	I-NP	I-protein
artery	artery	NN	I-NP	I-protein
occlusion	occlusion	NN	I-NP	I-protein
resultant	resultant	JJ	I-NP	I-protein
blindness	blindness	NN	I-NP	I-protein
OD	OD	NN	I-NP	I-protein
,	,	,	O	O
Lumbar	Lumbar	NNP	B-NP	O
laminectomy	laminectomy	NN	I-NP	O
,	,	,	O	O
Hx	Hx	NN	B-NP	O
Bladder	Bladder	NN	I-NP	O
Ca	Ca	NN	I-NP	O
***************	***************	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	SYM	O	O
iodine	iodine	NN	B-NP	O
contrast	contrast	NN	I-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NNP	B-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
Bisoprolol	Bisoprolol	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
Furosemide	Furosemide	NN	B-NP	O
scale	scale	NN	I-NP	O
60-80	60-80	CD	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	I-NP	O
Imdur	Imdur	NNP	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
50	50	CD	B-NP	O
units	unit	NNS	I-NP	O
+	+	SYM	B-NP	O
Humulin	Humulin	NNP	B-NP	O
SS	SS	NNP	I-NP	O
,	,	,	O	O
Proscar	Proscar	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
Folic	Folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Vitamin	Vitamin	NNP	B-NP	O
E	E	NNP	I-NP	O
400	400	CD	B-NP	O
units	unit	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
MVI	MVI	NN	B-NP	B-protein
,	,	,	O	O
Prednisone	Prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
Mg	Mg	NN	B-NP	O
+	+	SYM	O	O
+	+	SYM	O	O
120-240	120-240	CD	B-NP	O
mg	mg	NN	I-NP	O
HS	HS	NNP	B-NP	O
,	,	,	O	O
Nitroglycerin	Nitroglycerin	NNP	B-NP	O
spray	spray	NNP	I-NP	O
***************	***************	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
EXAM	EXAM	NNP	I-NP	O
Afeb	Afeb	NNP	I-NP	O
,	,	,	O	O
79	79	CD	B-NP	O
NSR	NSR	NN	I-NP	O
,	,	,	O	O
129/61	129/61	CD	B-NP	O
,	,	,	I-NP	O
20	20	CD	I-NP	O
,	,	,	I-NP	O
94	94	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
Weight	Weight	NN	I-NP	O
79.8	79.8	CD	I-NP	O
kg	kg	NN	I-NP	O
Coarse	Coarse	NN	I-NP	O
rales	rale	NNS	I-NP	O
1/2	1/2	CD	B-NP	O
up	up	IN	B-PP	O
Diffuse/Lat	Diffuse/Lat	NNP	B-NP	O
PMI	PMI	NNP	I-NP	O
,	,	,	O	O
3/6	3/6	CD	B-NP	O
HSM	HSM	NN	I-NP	O
to	to	TO	B-PP	O
axilla	axilla	NN	B-NP	O
,	,	,	O	O
2/6	2/6	CD	B-NP	O
SEM	SEM	NN	I-NP	O
at	at	IN	B-PP	O
LUSB	LUSB	NNP	B-NP	B-protein
,	,	,	O	O
occasional	occasional	JJ	B-NP	O
S3	S3	NN	I-NP	O
.	.	.	O	O

***************	***************	SYM	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
9/16	9/16	CD	B-NP	O
CXR	CXR	NN	I-NP	B-protein
-LRB-	-LRB-	SYM	B-NP	O
port	port	NN	I-NP	O
-RRB-	-RRB-	SYM	B-VP	O
-	-	HYPH	B-ADVP	O
no	no	DT	B-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
9/16	9/16	CD	I-NP	O
EKG	EKG	NN	I-NP	O
NSR	NSR	NN	I-NP	O
75	75	CD	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
dep	dep	NN	I-NP	O
and	and	CC	O	O
TWI	TWI	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	I-NP	O
aVF	aVF	NN	I-NP	O
.	.	.	O	O

J	J	NNP	B-NP	O
elev	elev	NN	I-NP	O
V2	V2	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
unchanged	unchanged	JJ	B-ADJP	I-protein
per	per	IN	B-PP	I-protein
Thuss	Thuss	NNP	B-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2/12	2/12	CD	I-NP	I-protein
CXR	CXR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PA/Lat	PA/Lat	NN	I-NP	I-protein
-RRB-	-RRB-	SYM	O	I-protein
-	-	HYPH	O	O
cardiomegaly	cardiomegaly	NN	B-NP	O
,	,	,	O	O
fluid	fluid	NN	B-NP	O
in	in	IN	B-PP	O
minor	minor	JJ	B-NP	O
fissure	fissure	NN	I-NP	O
on	on	IN	B-PP	O
R.	R.	NNP	B-NP	O
***************	***************	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
COURSE	COURSE	NNP	I-NP	O
73	73	CD	I-NP	O
yo	yo	NN	I-NP	O
M	M	NN	I-NP	O
with	with	IN	B-PP	O
known	know	VBN	B-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	I-NP	O
PCI	PCI	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
25-30	25-30	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	B-protein
,	,	,	O	O
IDDM	IDDM	NN	B-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV/Pump	CV/Pump	NN	B-NP	O
:	:	:	O	O
iCMP	iCMP	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
25-30	25-30	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NYHA	NYHA	NNP	I-NP	O
class	class	NN	I-NP	O
III	III	CD	I-NP	O
.	.	.	O	O

S/p	S/p	NN	B-NP	O
ICD	ICD	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
uncontrolled	uncontrolled	JJ	B-ADJP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

Admitted	Admit	VBN	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
decompensation	decompensation	NN	I-NP	O
with	with	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
and	and	CC	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
elevated	elevate	VBD	B-VP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
diurese	diurese	VB	I-VP	O
aggressively	aggressively	RB	B-ADVP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
of	of	IN	B-PP	O
dry	dry	JJ	B-NP	B-protein
weight	weight	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
175	175	CD	I-NP	I-protein
pounds	pound	NNS	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Not	Not	RB	B-ADVP	O
currently	currently	RB	I-ADVP	O
on	on	IN	B-PP	O
spironolactone	spironolactone	NN	B-NP	O
or	or	CC	I-NP	O
ACEI	ACEI	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
diuresis	diuresis	NN	B-NP	O
with	with	IN	B-PP	O
lasix	lasix	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

Weight	Weight	NN	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
goal	goal	NN	B-NP	O
of	of	IN	B-PP	O
175	175	CD	B-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

Starting	Start	VBG	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
afternoon	afternoon	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
for	for	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
each	each	DT	B-NP	O
pound	pound	NN	I-NP	O
over	over	IN	B-PP	O
175	175	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
take	take	VB	I-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CV/Ischemia	CV/Ischemia	NN	B-NP	O
:	:	:	O	O
known	know	VBN	B-NP	O
severe	severe	JJ	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	I-NP	O
PCI	PCI	NN	I-NP	B-protein
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
angina	angina	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Episode	Episode	VB	B-VP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
Tn	Tn	NN	B-NP	B-protein
became	become	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
to	to	TO	B-PP	O
0.33	0.33	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
downtrending	downtrende	VBG	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-NP	O
demand	demand	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypoxia/respiratory	hypoxia/respiratory	JJ	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
ST	ST	JJ	I-NP	O
depressions	depression	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
much	much	RB	I-VP	O
changed	change	VBN	I-VP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
resolved	resolve	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
ASA	ASA	NN	I-NP	O
and	and	CC	I-NP	O
plavix	plavix	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
intolerant	intolerant	JJ	B-ADJP	O
of	of	IN	B-PP	O
statins	statin	NNS	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CV/Rhythm	CV/Rhythm	NN	B-NP	O
:	:	:	O	O
PAF	PAF	NN	B-NP	B-protein
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
in	in	IN	B-PP	O
NSR	NSR	NN	B-NP	B-protein
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
level	level	NN	I-NP	O
0.4	0.4	CD	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
hypoxia	hypoxia	NN	B-NP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

However	However	RB	B-NP	O
CXR	CXR	NN	I-NP	B-protein
with	with	IN	B-PP	O
little	little	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
edema	edema	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
saturation	saturation	NN	I-NP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
felt	feel	VBD	B-VP	O
symptomatically	symptomatically	RB	B-ADJP	O
better	good	JJR	I-ADJP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
ARF	ARF	NN	B-NP	B-protein
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
Cr	Cr	NN	I-NP	O
1.2	1.2	CD	I-NP	O
.	.	.	O	O

Likely	Likely	RB	B-NP	O
2/2	2/2	CD	I-NP	O
DM	DM	NN	I-NP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	O
protein/creatinine	protein/creatinine	NN	I-NP	O
pending	pende	VBG	B-VP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
anticoagulation	anticoagulation	NN	B-NP	O
with	with	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
Goal	Goal	NN	I-NP	O
INR	INR	NN	I-NP	O
2.0	2.0	CD	B-NP	O
to	to	TO	I-NP	O
3.0	3.0	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Vascular	Vascular	JJ	B-ADJP	O
:	:	:	O	O
PVD	PVD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
revascularization	revascularization	NN	I-NP	O
.	.	.	O	O

Magnesium	Magnesium	NN	B-NP	O
for	for	IN	B-PP	O
leg	leg	NN	B-NP	O
cramps	cramp	NNS	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
low	low	JJ	B-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
gm	gm	NN	I-NP	O
sodium	sodium	NN	I-NP	O
,	,	,	O	O
2L	2L	NN	B-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
.	.	.	O	O

Replacing	Replace	VBG	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
aggressively	aggressively	RB	B-ADVP	O
.	.	.	O	O

Has	Ha	NNS	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scalre	scalre	NN	B-NP	O
K	K	NN	I-NP	O
replacement	replacement	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Continue	Continue	NN	B-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
and	and	CC	I-NP	O
potassium	potassium	NN	I-NP	O
on	on	IN	B-PP	O
your	your	PRP$	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Continue	Continue	VB	B-VP	O
your	your	PRP$	B-NP	B-protein
original	original	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

Weigh	Weigh	VB	B-VP	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Continue	Continue	VB	B-VP	O
your	your	PRP$	B-NP	O
original	original	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
medications	medication	NNS	I-NP	O
***********	***********	SYM	B-NP	O
NEW	NEW	JJ	I-NP	O
AFTERNOON	AFTERNOON	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
SCALE	SCALE	NN	I-NP	O
Take	Take	VB	B-VP	O
your	your	PRP$	B-NP	O
afternoon	afternoon	NN	I-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
every	every	DT	B-NP	O
pound	pound	NN	I-NP	O
over	over	IN	B-PP	O
175	175	CD	B-NP	O
,	,	,	O	O
take	take	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
diuretics	diuretic	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
other	other	JJ	B-NP	O
options	option	NNS	I-NP	O
for	for	IN	B-PP	O
lipid	lipid	NN	B-NP	O
lowering	lower	VBG	B-VP	O
-LRB-	-LRB-	NN	B-NP	O
ie	ie	NN	I-NP	O
ezetimibe	ezetimibe	NN	I-NP	O
,	,	,	O	O
cholestryramine	cholestryramine	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Consider	Consider	VB	B-VP	O
tighter	tight	JJR	B-NP	O
diabetes	diabete	NNS	I-NP	O
control	control	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
are	be	VBP	B-VP	O
80s	80s	CD	B-NP	O
to	to	TO	B-PP	O
300s	300s	CD	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
adding	add	VBG	I-VP	O
back	back	RB	B-ADVP	O
ACEI	ACEI	NN	B-NP	O
when	when	WRB	B-ADVP	O
tolerable	tolerable	JJ	B-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Consider	Consider	VB	B-VP	O
spironolactone	spironolactone	NN	B-NP	O
for	for	IN	B-PP	O
class	class	NN	B-NP	O
III	III	CD	I-NP	O
CHF	CHF	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
K	K	NN	B-NP	O
retention	retention	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
INR	INR	NN	I-NP	O
and	and	CC	I-NP	O
titrate	titrate	NN	I-NP	B-protein
coumadin	coumadin	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

f/u	f/u	NN	B-NP	O
HbA1c	HbA1c	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
ELLS	ELLS	NNP	B-NP	O
,	,	,	O	O
CLIFFORD	CLIFFORD	NNP	B-NP	O
P.	P.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PE26	PE26	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/12/06	5/12/06	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

